Tag: AHA 2023
VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk patient populations
New analyses from the...
SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide
Results of the SELECT cli...
